Roberts JA - Search Results

1

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis.

Abdul-Aziz MH, Sulaiman H, Mat-Nor MB, Rai V, Wong KK, Hasan MS, Abd Rahman AN, Jamal JA, Wallis SC, Lipman J, Staatz CE, Roberts JA. Abdul-Aziz MH, et al. Among authors: roberts ja. Intensive Care Med. 2016 Oct;42(10):1535-1545. doi: 10.1007/s00134-015-4188-0. Epub 2016 Jan 11. Intensive Care Med. 2016. PMID: 26754759 Clinical Trial.

2

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.

Roberts JA, Lipman J. Roberts JA, et al. Clin Pharmacokinet. 2006;45(8):755-73. doi: 10.2165/00003088-200645080-00001. Clin Pharmacokinet. 2006. PMID: 16884316 Review.

3

Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study.

Roberts JA, Boots R, Rickard CM, Thomas P, Quinn J, Roberts DM, Richards B, Lipman J. Roberts JA, et al. Among authors: roberts dm. J Antimicrob Chemother. 2007 Feb;59(2):285-91. doi: 10.1093/jac/dkl478. Epub 2006 Nov 28. J Antimicrob Chemother. 2007. PMID: 17135183 Clinical Trial.

4

Cefepime versus ceftazidime: considerations for empirical use in critically ill patients.

Roberts JA, Webb SA, Lipman J. Roberts JA, et al. Int J Antimicrob Agents. 2007 Feb;29(2):117-28. doi: 10.1016/j.ijantimicag.2006.08.031. Epub 2006 Dec 8. Int J Antimicrob Agents. 2007. PMID: 17158033 Review.

5

Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role.

Roberts JA, Paratz J, Paratz E, Krueger WA, Lipman J. Roberts JA, et al. Int J Antimicrob Agents. 2007 Jul;30(1):11-8. doi: 10.1016/j.ijantimicag.2007.02.002. Epub 2007 Apr 17. Int J Antimicrob Agents. 2007. PMID: 17442541 Review.

6

A novel way to investigate the effects of plasma exchange on antibiotic levels: use of microdialysis.

Roberts JA, Roberts MS, Robertson TA, Cross SE, Lipman J. Roberts JA, et al. Among authors: roberts ms. Int J Antimicrob Agents. 2008 Mar;31(3):240-4. doi: 10.1016/j.ijantimicag.2007.09.013. Epub 2007 Dec 4. Int J Antimicrob Agents. 2008. PMID: 18054829

7

Optimizing use of beta-lactam antibiotics in the critically ill.

Roberts JA, Lipman J. Roberts JA, et al. Semin Respir Crit Care Med. 2007 Dec;28(6):579-85. doi: 10.1055/s-2007-996404. Semin Respir Crit Care Med. 2007. PMID: 18095221 Review.

8

Continuous infusion of beta-lactams in the intensive care unit--best way to hit the target?

Roberts JA, Paratz JD, Lipman J. Roberts JA, et al. Crit Care Med. 2008 May;36(5):1663-4. doi: 10.1097/CCM.0b013e3181704625. Crit Care Med. 2008. PMID: 18448930 No abstract available.

9

Lessons learnt in the pharmacokinetic analysis of the effect of haemoperfusion for acute overdose with sustained-release diltiazem.

Roberts DM, Roberts JA, Boots RJ, Mason R, Lipman J. Roberts DM, et al. Among authors: roberts ja. Anaesthesia. 2008 Jul;63(7):714-8. doi: 10.1111/j.1365-2044.2008.05477.x. Anaesthesia. 2008. PMID: 18582256 Free article.

10

Antibiotic resistance--what's dosing got to do with it?

Roberts JA, Kruger P, Paterson DL, Lipman J. Roberts JA, et al. Crit Care Med. 2008 Aug;36(8):2433-40. doi: 10.1097/CCM.0b013e318180fe62. Crit Care Med. 2008. PMID: 18596628 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,471 results

Search Page